Skip to main content

Table 3 Causes of death

From: Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors

  Group I (4 × 3.8 Gy) Group II (2 × 7.2 Gy)
Fatal hemoptysis 18.3% 12.2%
Other reason than tumor progression 13.3% 8.5%
Local problems 20% 32.9%
Unknown 15% 12.2%